Navigation Links
Quorum Review IRB Board Chair Appointed to SACHRP
Date:7/18/2013

Seattle, WA (PRWEB) July 18, 2013

Quorum Review IRB, the industry leader in central IRB services, announces its Board Chair, Stephen Rosenfeld, MD, MBA, has been appointed to the Secretary’s Advisory Committee on Human Research Protections (SACHRP). This exclusive panel is selected from the best minds in the research industry to advise the Secretary of Health and Human Services in the area of human research subjects. Kathleen Sibelius is the current Secretary of HHS and has served in that post since her appointment by President Barack Obama in 2009. The Committee was created by previous Secretary Tommy Thompson in 2001.

Dr. Rosenfeld has served in his current role for Quorum Review IRB since January 2012. He brings a wealth of knowledge and expertise to Quorum as well as to his new appointment on the Secretary’s Advisory Committee. Dr. Rosenfeld earned his undergraduate degree in Physics from Yale University in New Haven, CT. He went on to become an MD at Cornell University Medical College in New York. Later, he achieved his MBA status at Georgetown University’s McDonough School of Business in Washington D.C.

Prior to his work with Quorum Review, Dr. Rosenfeld served as the President and CEO of Western IRB in Olympia, WA. He has also held prominent positions with MaineHealth, the Clinical Center at the National Institutes of Health, and the National Heart, Lung, and Blood Institute. He has also been Board-certified in Hematology and Internal Medicine.

Rosenfeld says, "It's a privilege to serve on the Secretary's Advisory Committee as the research enterprise grapples with ethical, regulatory and practical issues that were not envisaged at the time the regulations were written; they include ethical oversight of multi-site trials, genomics and re-identification, and the use of technology and social media in research."

For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.

About Quorum Review IRB
Quorum Review is an independent review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10934693.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
2. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
3. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
4. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
5. Nonprofit Consortium Publishes Review of Skullcap Adulteration
6. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
7. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
8. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials
9. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
10. Alzheimers Therapeutics Reviewed by NeuroPerspective
11. Peer Reviewed Clinical Study Shows New Blood Test More Accurately Predicts Risk Of A Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... 03, 2016 , ... According to world renowned prostate cancer surgeon, Dr. ... traditionally had two main treatment options: surgery or radiation. Based on a patient’s goals, ... technology has enabled doctors to administer higher doses of radiation to prostate ...
(Date:5/2/2016)... ... May 02, 2016 , ... F.E.E.D. Co., the Feline Environmental ... revolutionary, veterinarian-designed product for indoor cats. The NoBowl Feeding System replaces the bowl ... the way nature intended. NoBowls make cats happy and healthy. , Since being ...
(Date:4/29/2016)... ... April 29, 2016 , ... During a two ... into a viable company, CereScan’s CEO, John Kelley, joined other Denver business leaders ... and mentor in the Denver area business community, shared his top fundamental learnings ...
(Date:4/28/2016)... , April 28, 2016 ... reports the Company,s CEO  was featured in an ... Enter When VCs Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... magazine is an essential business journal ... from emerging biotechs to Big Pharmas. Their content ...
Breaking Biology Technology:
(Date:3/10/2016)... -- --> --> ... Access Management Market by Component (Provisioning, Directory Services, Password ... Size, by Deployment, by Vertical, and by Region - ... is estimated to grow from USD 7.20 Billion in ... Compound Annual Growth Rate (CAGR) of 12.2% during the ...
(Date:3/9/2016)... Fla. , March 9, 2016  Crossmatch ... authentication and enrollment solutions, today announced the addition ... ® Altus multi-factor authentication platform. New ... InfoSec managers to step-up security where it,s needed ... Washington, DC . --> ...
(Date:3/3/2016)... NOTTINGHAM, England and DE SOTO, ... , U.S.-based Stroke Detection Plus® to offer Oncimmune,s ... the risk assessment and early detection of lung cancer ... include large employers, unions and individuals. --> ... employers, unions and individuals. --> Oncimmune, a ...
Breaking Biology News(10 mins):